Axsome to Present Results of SHARP Study at Psych Congress
Axsome is set to present new data on Sunosi (solriamfetol) in patients with excessive daytime sleepiness (EDS) due to narcolepsy and OSA.
Source: sleepreviewmag.com
Effect Sizes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Effect Sizes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Effect Sizes Today - Breaking & Trending Today
Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...
Source: marketscreener.com
Axsome to Present New Sunosi Data at SLEEP 2023
Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.
Source: sleepreviewmag.com
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 -- Axsome Therapeutics, Inc. , a... | June 1, 2023
Source: marketscreener.com
How Effective Are Therapy and Medication, and What Do They Treat?
In our science news podcast, Peter Simons covers a study that found both therapy and medication to have very limited effectiveness.
Source: madinamerica.com